Clinical Trials
14 trialsNCT03993353 2026-02-12
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
Phase 2 Completed
NCT03383094 2025-10-07
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
University of California, San Diego
Phase 2 Active not recruiting
NCT04116073 2025-07-29
INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT05626569 2024-01-03
Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC
Sun Yat-sen University
Phase 2 Unknown
NCT04271384 2023-12-26
Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer
Hospital Israelita Albert Einstein
Phase 2 Completed
NCT05281003 2023-07-13
HYPERION
Fudan University
Phase 2 Recruiting
NCT05941338 2023-07-12
HNC-SYSU-001
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Recruiting
NCT05386056 2022-11-28
Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma
Peking University
Phase 2 Unknown
NCT05519202 2022-08-29
Exploratory Clinical Study of Penpulimab Combined With SOX in the Perioperative Treatment of Gastric Cancer
The Central Hospital of Lishui City
Phase 2 Unknown
NCT02968940 2022-06-29
Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma
NYU Langone Health
Phase 2 Completed
NCT04812002 2022-06-03
Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy
Women's Hospital School Of Medicine Zhejiang University
Phase 2 Unknown
NCT05392686 2022-05-26
PD1 and PARP for Maintenance Therapy in NSLLC
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT02549209 2022-03-02
Pembro/Carbo/Taxol in Endometrial Cancer
Big Ten Cancer Research Consortium
Phase 2 Completed
NCT04530227 2020-11-13
Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLC
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown